Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does sarcoma occur in man after intramuscular iron?

J Fielding

    Scandinavian Journal of Haematology. Supplementum
    |January 1, 1977
    PubMed
    Summary

    High-dose iron carbohydrate complex injections can cause sarcomas in animals, with factors like species, dose, and residual iron influencing tumor development. Causal links in humans remain uncertain despite reported cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal Ganglia.

    AJNR. American journal of neuroradiology·2022
    Same author

    Constructing an ethical framework for priority allocation of pandemic vaccines.

    Vaccine·2021
    Same author

    Cognitive processing speed deficits in multiple sclerosis: Dissociating sensorial and motor processing changes from cognitive processing speed.

    Multiple sclerosis and related disorders·2019
    Same author

    Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review.

    BMC medical research methodology·2019
    Same author

    Multiple sclerosis: Executive dysfunction, task switching and the role of attention.

    Multiple sclerosis journal - experimental, translational and clinical·2018
    Same author

    Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females.

    Translational psychiatry·2016

    Area of Science:

    • Oncology
    • Toxicology
    • Biomedical Science

    Background:

    • Iron carbohydrate complexes are used medically, but potential oncogenic risks require thorough investigation.
    • Previous studies indicate that high doses of these complexes can induce sarcomas in certain animal models.
    • Understanding the factors influencing sarcoma induction is crucial for assessing human health risks.

    Purpose of the Study:

    • To investigate the factors influencing sarcoma induction following iron carbohydrate complex injection in animal models.
    • To critically review reported cases of human malignancies potentially linked to iron-dextran injections.
    • To evaluate the evidence for a causal relationship between iron-dextran and human sarcomas.

    Main Methods:

    • Animal studies involving iron carbohydrate complex injections across different species (rats, mice, hamsters, guinea pigs, dogs).
    • Dose-response analysis to determine threshold effects and tumor yield.
    • Assessment of residual iron at injection sites to evaluate local oncogenesis.
    • Critical review and analysis of published human case reports (1960-1977) of malignancies after iron-dextran administration.

    Main Results:

    • Sarcoma induction was observed in rats, mice, and hamsters, but not in guinea pigs or dogs, indicating species specificity.
    • A clear dose-response relationship was established, with increased tumor incidence at higher doses.
    • Local oncogenesis was linked to the amount of residual iron at the injection site.
    • A probable human latent period of 15-20 years was estimated.
    • Out of nine reported human malignancies, only one case presented sufficient evidence to suggest a probable link to iron-dextran-induced sarcoma.

    Conclusions:

    • Sarcoma induction by iron carbohydrate complexes is influenced by species, dose, residual iron, and latent period.
    • While animal studies demonstrate oncogenic potential, the evidence for a causal relationship in humans is currently limited to a single probable case.
    • Further research and long-term monitoring are necessary to definitively establish or refute the oncogenic risk of iron-dextran in humans, especially considering the commonality of soft tissue tumors.

    Related Experiment Videos